These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 25869137)

  • 21. Revisiting autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) mutations in the nicotinic acetylcholine receptor reveal an increase in efficacy regardless of stochiometry.
    Indurthi DC; Qudah T; Liao VW; Ahring PK; Lewis TM; Balle T; Chebib M; Absalom NL
    Pharmacol Res; 2019 Jan; 139():215-227. PubMed ID: 30472464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-I A-85380 and TC-2559 differentially activate heterologously expressed alpha4beta2 nicotinic receptors.
    Zwart R; Broad LM; Xi Q; Lee M; Moroni M; Bermudez I; Sher E
    Eur J Pharmacol; 2006 Jun; 539(1-2):10-7. PubMed ID: 16674940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Covalent trapping of methyllycaconitine at the α4-α4 interface of the α4β2 nicotinic acetylcholine receptor: antagonist binding site and mode of receptor inhibition revealed.
    Absalom NL; Quek G; Lewis TM; Qudah T; von Arenstorff I; Ambrus JI; Harpsøe K; Karim N; Balle T; McLeod MD; Chebib M
    J Biol Chem; 2013 Sep; 288(37):26521-32. PubMed ID: 23893416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The additional ACh binding site at the α4(+)/α4(-) interface of the (α4β2)2α4 nicotinic ACh receptor contributes to desensitization.
    Benallegue N; Mazzaferro S; Alcaino C; Bermudez I
    Br J Pharmacol; 2013 Sep; 170(2):304-16. PubMed ID: 23742319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Augmentation of cognitive function by NS9283, a stoichiometry-dependent positive allosteric modulator of α2- and α4-containing nicotinic acetylcholine receptors.
    Timmermann DB; Sandager-Nielsen K; Dyhring T; Smith M; Jacobsen AM; Nielsen EØ; Grunnet M; Christensen JK; Peters D; Kohlhaas K; Olsen GM; Ahring PK
    Br J Pharmacol; 2012 Sep; 167(1):164-82. PubMed ID: 22506660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The fifth subunit of the (α4β2)
    New K; Del Villar SG; Mazzaferro S; Alcaino C; Bermudez I
    Br J Pharmacol; 2018 Jun; 175(11):1822-1837. PubMed ID: 28600847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Photolabeling a Nicotinic Acetylcholine Receptor (nAChR) with an (α4)3(β2)2 nAChR-Selective Positive Allosteric Modulator.
    Hamouda AK; Deba F; Wang ZJ; Cohen JB
    Mol Pharmacol; 2016 May; 89(5):575-84. PubMed ID: 26976945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attenuation of nicotine taking and seeking in rats by the stoichiometry-selective alpha4beta2 nicotinic acetylcholine receptor positive allosteric modulator NS9283.
    Maurer JJ; Sandager-Nielsen K; Schmidt HD
    Psychopharmacology (Berl); 2017 Feb; 234(3):475-484. PubMed ID: 27844094
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Orthosteric and allosteric potentiation of heteromeric neuronal nicotinic acetylcholine receptors.
    Wang J; Lindstrom J
    Br J Pharmacol; 2018 Jun; 175(11):1805-1821. PubMed ID: 28199738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Engineering α4β2 nAChRs with reduced or increased nicotine sensitivity via selective disruption of consensus sites in the M3-M4 cytoplasmic loop of the α4 subunit.
    Biaggi-Labiosa NM; Avilés-Pagán E; Caballero-Rivera D; Báez-Pagán CA; Lasalde-Dominicci JA
    Neuropharmacology; 2015 Dec; 99():273-84. PubMed ID: 25957813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. alpha4beta2 nicotinic receptors with high and low acetylcholine sensitivity: pharmacology, stoichiometry, and sensitivity to long-term exposure to nicotine.
    Moroni M; Zwart R; Sher E; Cassels BK; Bermudez I
    Mol Pharmacol; 2006 Aug; 70(2):755-68. PubMed ID: 16720757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rare human nicotinic acetylcholine receptor α4 subunit (CHRNA4) variants affect expression and function of high-affinity nicotinic acetylcholine receptors.
    McClure-Begley TD; Papke RL; Stone KL; Stokes C; Levy AD; Gelernter J; Xie P; Lindstrom J; Picciotto MR
    J Pharmacol Exp Ther; 2014 Mar; 348(3):410-20. PubMed ID: 24385388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nicotinic Acetylcholine Receptor Accessory Subunits Determine the Activity Profile of Epibatidine Derivatives.
    Corrie LW; Stokes C; Wilkerson JL; Carroll FI; McMahon LR; Papke RL
    Mol Pharmacol; 2020 Oct; 98(4):328-342. PubMed ID: 32690626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AE Succinimide, an Analogue of Methyllycaconitine, When Bound Generates a Nonconducting Conformation of the α4β2 Nicotinic Acetylcholine Receptor.
    Qudah T; Quek GX; Indurthi D; Karim N; Halliday JI; Absalom N; McLeod MD; Chebib M
    ACS Chem Neurosci; 2020 Feb; 11(3):344-355. PubMed ID: 31898891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-equivalent ligand selectivity of agonist sites in (α4β2)2α4 nicotinic acetylcholine receptors: a key determinant of agonist efficacy.
    Mazzaferro S; Gasparri F; New K; Alcaino C; Faundez M; Iturriaga Vasquez P; Vijayan R; Biggin PC; Bermudez I
    J Biol Chem; 2014 Aug; 289(31):21795-806. PubMed ID: 24936069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sazetidine-A is a potent and selective agonist at native and recombinant alpha 4 beta 2 nicotinic acetylcholine receptors.
    Zwart R; Carbone AL; Moroni M; Bermudez I; Mogg AJ; Folly EA; Broad LM; Williams AC; Zhang D; Ding C; Heinz BA; Sher E
    Mol Pharmacol; 2008 Jun; 73(6):1838-43. PubMed ID: 18367540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stoichiometry and pharmacology of two human alpha4beta2 nicotinic receptor types.
    Moroni M; Bermudez I
    J Mol Neurosci; 2006; 30(1-2):95-6. PubMed ID: 17192644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roles of nicotinic acetylcholine receptor beta subunits in function of human alpha4-containing nicotinic receptors.
    Wu J; Liu Q; Yu K; Hu J; Kuo YP; Segerberg M; St John PA; Lukas RJ
    J Physiol; 2006 Oct; 576(Pt 1):103-18. PubMed ID: 16825297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Novel α2/α4 Subtype-selective Positive Allosteric Modulator of Nicotinic Acetylcholine Receptors Acting from the C-tail of an α Subunit.
    Wang J; Kuryatov A; Jin Z; Norleans J; Kamenecka TM; Kenny PJ; Lindstrom J
    J Biol Chem; 2015 Nov; 290(48):28834-46. PubMed ID: 26432642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identifying the binding site of novel methyllycaconitine (MLA) analogs at α4β2 nicotinic acetylcholine receptors.
    Quek GX; Lin D; Halliday JI; Absalom N; Ambrus JI; Thompson AJ; Lochner M; Lummis SC; McLeod MD; Chebib M
    ACS Chem Neurosci; 2010 Dec; 1(12):796-809. PubMed ID: 22778816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.